Düzgün Özatlı

520 total citations
30 papers, 369 citations indexed

About

Düzgün Özatlı is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Düzgün Özatlı has authored 30 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 6 papers in Immunology. Recurrent topics in Düzgün Özatlı's work include Platelet Disorders and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Düzgün Özatlı is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Düzgün Özatlı collaborates with scholars based in Türkiye, Cyprus and Romania. Düzgün Özatlı's co-authors include İbrahim C. Haznedaroğlu, Nuriye Taşdelen Fışgın, Ahmet Yılmaz Çoban, Semra Dündar, Yahya Büyükaşık, Yeliz Tanrıverdi Çaycı, Belma Durupınar, Necla Tülek, Osman Özcebe and Esra Tanyel and has published in prestigious journals such as Journal of Clinical Oncology, Fitoterapia and Clinical Rheumatology.

In The Last Decade

Düzgün Özatlı

26 papers receiving 342 citations

Peers

Düzgün Özatlı
Satoru Takada Japan
Türker Çetin Türkiye
P. Capel Belgium
Tiziana Spatola Italy
Sumitra Dash India
Suzanne Beaudin Canada
Napaporn Archararit Thailand
F García‐Bragado Spain
E. Shannon Cooper United States
Larisa Dzirlo Austria
Satoru Takada Japan
Düzgün Özatlı
Citations per year, relative to Düzgün Özatlı Düzgün Özatlı (= 1×) peers Satoru Takada

Countries citing papers authored by Düzgün Özatlı

Since Specialization
Citations

This map shows the geographic impact of Düzgün Özatlı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Düzgün Özatlı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Düzgün Özatlı more than expected).

Fields of papers citing papers by Düzgün Özatlı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Düzgün Özatlı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Düzgün Özatlı. The network helps show where Düzgün Özatlı may publish in the future.

Co-authorship network of co-authors of Düzgün Özatlı

This figure shows the co-authorship network connecting the top 25 collaborators of Düzgün Özatlı. A scholar is included among the top collaborators of Düzgün Özatlı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Düzgün Özatlı. Düzgün Özatlı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özatlı, Düzgün, et al.. (2024). A RARE CAUSE OF THROMBOCYTOPENIA: MALARIA. Hematology Transfusion and Cell Therapy. 46. S64–S65.
2.
Dal, Mehmet Sinan, Tuğçe Nur Yiğenoğlu, Semih Başçı, et al.. (2023). Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey. Journal of Chemotherapy. 35(6). 563–569. 2 indexed citations
3.
4.
Korkmaz, Serdal, Mehmet Ali Erkurt, İlhami Berber, et al.. (2021). Apheresis in patients with sepsis: A multicenter retrospective study. Transfusion and Apheresis Science. 60(5). 103239–103239. 2 indexed citations
5.
6.
Erdem, Di̇lek, Hasan Alaçam, Yüksel Bek, et al.. (2014). The Relationship of T Helper-2 Pathway Components Interleukin-4, Interleukin-10, Immunoglobulin E, and Eosinophils with Prognostic Markers in Non-Hodgkin Lymphoma: A Case-Control Study. Turkish Journal of Hematology. 31(4). 381–387. 1 indexed citations
7.
Terzi, Yüksel, et al.. (2013). Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio. Annals of Hematology. 93(5). 841–846. 46 indexed citations
8.
Deveci, Aydın, Ahmet Yılmaz Çoban, Yeliz Tanrıverdi Çaycı, et al.. (2013). In Vitro Effect of Ankaferd Blood Stopper®, a Plant Extract Against Mycobacterium tuberculosis Isolates. Mikrobiyoloji Bulteni. 47(1). 71–78. 13 indexed citations
9.
Demir, Ayşe Y., et al.. (2013). Incidence of the JAK2V617F Mutation in Chronic Myeloproliferative Disorders. 3(2). 1–1. 1 indexed citations
10.
Özatlı, Düzgün, et al.. (2011). Lökosit Üretiminde Yetersizlik ile Giden Kazanılmış Hastalıklar. 4(1). 56–58.
11.
Özatlı, Düzgün, Hakan Göker, Yahya Büyükaşık, et al.. (2009). The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 388–394.
12.
Fışgın, Nuriye Taşdelen, Yeliz Tanrıverdi Çaycı, Ahmet Yılmaz Çoban, et al.. (2008). Antimicrobial activity of plant extract Ankaferd Blood Stopper®. Fitoterapia. 80(1). 48–50. 98 indexed citations
13.
Yapıcı, Oktay, et al.. (2007). Acute Complete Splenic Infarction in a Patient with Hirschsprung’s Disease and Literature Review of Complete Splenic Infarction. Pathophysiology of Haemostasis and Thrombosis. 36(2). 102–104. 2 indexed citations
14.
Çobankara, Veli, Düzgün Özatlı, Sedat Kiraz, et al.. (2004). Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level. Clinical Rheumatology. 23(5). 430–434. 14 indexed citations
15.
Karakuş, Sema, İbrahim C. Haznedaroğlu, Hakan Göker, et al.. (2003). Bone Marrow and Peripheral Blood C-kit Ligand Concentrations in Patients with Thrombocytosis and Thrombocytopenia. Hematology. 8(6). 369–373. 5 indexed citations
16.
Büyükaşık, Yahya, Sema Karakuş, Hakan Göker, et al.. (2002). Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagulation & Fibrinolysis. 13(4). 349–353. 34 indexed citations
17.
Özatlı, Düzgün, Nilgün Sayınalp, Yahya Büyükaşık, et al.. (2001). Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state. Rheumatology International. 21(4). 137–140. 17 indexed citations
18.
Çobankara, Veli, Düzgün Özatlı, İbrahim C. Haznedaroğlu, et al.. (1999). CIRCULATING PROTEIN-Z IN REACTIVE VERSUS PRIMARY THROMBOCYTOSIS AND IN ITP. 43(2). 65–72. 1 indexed citations
19.
Özatlı, Düzgün, et al.. (1999). Circulating thrombomodulin, thrombospondin, and fibronectin in acute myeloblastic leukemias.. PubMed. 29(4). 277–83. 7 indexed citations
20.
Büyükaşık, Yahya, Selma Karaahmetoğlu, Düzgün Özatlı, et al.. (1999). Evaluation of the Haemostatic System during Ketoacidotic Deterioration of Diabetes mellitus. Pathophysiology of Haemostasis and Thrombosis. 29(6). 318–325. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoru Takada Breakdown of academic impact, for papers by Türker Çetin Breakdown of academic impact, for papers by P. Capel Breakdown of academic impact, for papers by Tiziana Spatola Breakdown of academic impact, for papers by Sumitra Dash Breakdown of academic impact, for papers by Suzanne Beaudin Breakdown of academic impact, for papers by Napaporn Archararit Breakdown of academic impact, for papers by F García‐Bragado Breakdown of academic impact, for papers by E. Shannon Cooper Breakdown of academic impact, for papers by Larisa Dzirlo
Rankless by CCL
2026